Hoersholm, 2011-11-29 18:33 CET (GLOBE NEWSWIRE) --
Company announcement no.25/2011
At the Annual General Meeting of Chr. Hansen Holding A/S held on 29 November 2011, the following business was transacted:
- Adoption of the Annual Report 2010/11.
- It was resolved to pay a dividend of DKK 3.57 per share of DKK 10.
- It was resolved to adapt the Remuneration Policy for Chr. Hansen Holding A/S and the Overall Guidelines for Incentive-based Remuneration for Chr. Hansen Holding A/S' Management, which have been produced by the Board of Directors.
- It was resolved to remunerate board members with a base remuneration of DKK 300,000. However, the Chairman will receive DKK 900,000, corresponding to three (3) times the base remuneration, and the Vice Chairman DKK 450,000 corresponding to one and a half (1.5) times the base remuneration. In addition to the remuneration to the members of the Board of Directors, it was resolved to remunerate committee positions with DKK 100,000, however the Chairman of the Audit Committee will receive a remuneration of DKK 150,000.
- Ole Andersen was re-elected Chairman of the Board of Directors.
- Frédéric Stévenin, Gaëlle d’Engremont, Henrik Poulsen and Mark Wilson were re-elected to the Board of Directors. Didier Debrosse was elected as new member of the Board of Directors.
- PricewaterhouseCoopers, Statsautoriseret Revisionspartnerselskab was re-elected as auditor of the Company.
- The Board of Directors was authorized in the period until 29 November 2016 to increase the Company’s share capital by up to nominally DKK 130 million. The capital increase may be effected by payment in cash or by contribution of other assets than cash. If the capital increase is effected by payment in cash at market price or by contribution of other assets than cash, the Board of Directors may decide that the capital increase shall take place without pre-emption rights to the Company’s existing shareholders.
- The Chairman of the Annual General Meeting was authorized to apply for registration of the resolutions passed with the Danish Commerce and Companies Agency and to make such amendments thereto as may be required or requested by the Danish Commerce and Companies Agency as a condition for registration or approval.
For further information, please contact:
Ole Andersen, Chariman
Tel.: +45 4574 7474
Lars Frederiksen, CEO
Tel.: +45 4574 7474
Anders Mohr Christensen, Investor Relations
Tel: +45 4574 7618
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. There are more than 2,300 dedicated employees in over 30 countries. For further information, please visit www.chr-hansen.com.
